+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Life Science Reagents- Use of Biotechnology-based Diagnostic Tools to Provide Lucrative Opportunities, says TMR

Posted on Sep 28, 2016

The global life science reagents market is fragmented with Sigma Aldrich Corporation, Life Technologies, and GE Healthcare being the top three players. The requirement for high initial capital and stringent regulatory norms are discouraging new players from entering the market. A need for skilled labor and strong distribution network are other challenges that need to be faced for entering the market, states a new report by Transparency Market Research (TMR). On account of all these factors, the threat of new entrants is expected to be low. The threat of substitutes is also expected to be low as the only feasible substitute available is reused reagents. 

According to the report, the global life science reagents market is expected to be worth US$25,731.9 mn in 2019. On the basis of product, the chromatography reagents segment is expected to lead account for 28.5% by 2019. By end user, the research and academics segment will continue to remain the dominant segment, accounting for 37.2% of the market by 2019. The North America life science reagents market will be worth US$10,303 mn by 2019. However, Asia Pacific is expected to expand at a high CAGR from 2013 to 2019. 

Technological Advancements to be Biggest Factor Driving Demand 

With advancements in technology, the application areas of biotechnology and life sciences are growing and this is fueling the growth of the global life science reagents market. Technological advancements in the field of cell and tissue culture have propelled the growth of the market in the areas of microbiology, antibiotics, and diagnostic testing. 

Another factor driving the growth of the life science reagents market is the development of chromatography, electrophoresis and flow cytometry techniques and their application in the healthcare industry. These techniques are being used for disease diagnostics and treatment monitoring, thus boosting the market. Government initiatives worldwide to strengthen the healthcare sector by concentrating on the development of biotechnology sector are also pushing the market towards growth. 

Larger Patent Repository of Players Restraining Entry of New Players 

Although developing countries such as India and China are anticipated to witness significantly high growth in the field of innovation and technology, the patent repository of the players in these countries is smaller as compared to that of matured market players. Larger patent repository of players is thus, restraining the entry of new market players in the market. This is restraining the growth of the life science reagents market. 

While big healthcare organizations and research institutes can afford life science research and development activities, smaller organizations cannot. Purchasing the sophisticated instrumentation required for research of life science products is difficult and the maintenance cost is also high, which is restricting the growth of the market. Additionally, a dearth of skilled labor is also hampering the growth of the market. 

Growing Scope of In-vitro Diagnostics to Benefit Life Science Reagents Market 

Use of biotechnology-based diagnostic tools is increasing in the diagnosis of various life-threatening diseases such as cancer, viral infections, and Alzheimer’s diseases. This is expected to provide lucrative opportunities for the life science reagents market, particularly in the in-vitro diagnostics field in the coming years. Another factor emerging as an opportunity in the market is the impressive growth potential of the emerging nations in the APAC region. 

This information is based on the findings of a report published by Transparency Market Research titled “Life Science Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2013 - 2019.” 

The global life science reagents market is segmented as follows: 

Product Type

  • Polymerase chain reaction (PCR) reagent kits
  • Cell and tissue culture reagents
  • Flow cytometry reagents
  • Electrophoresis reagents
  • Chromatography reagents
  • In-vitro diagnostics (IVD) reagents
  • Others (gene expression reagents, mass spectroscopy reagents and transfection reagents) 

End User

  • Commercial and contract manufacturers
  • Research and academic institutions
  • Clinical laboratories
  • Forensic laboratories 

Geography

  • North America
  • Europe 
  • Asia-Pacific
  • Rest of the World 

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

Back To Top